slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 18,031-18,060
Pages 3,950
Rows per page 30
Component
18,031-18,060 of 118,471
09
The tone is highly critical, using terms like 'dumpster fire'.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Impact & Next StepsLoop · The Reveal3 hits
14
Includes a screenshot of a Badcock advertisement and a line chart showing the rapid increase in FRG's provision for doubtful accounts.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · SolutionLoop · Iceberg3 hits
16
The slide uses a short-seller research style to critique the financial viability of the company's bankruptcy plan.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller 3 hits
18
Highlights the sensitivity of the ending cash balance to hosting payment assumptions.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller 3 hits
05
Includes screenshots from Qixinbao and the China MIIT website to substantiate the license cancellation.Moxian, Inc. (MOXC) · Wolfpack Research
Research note Short seller Beat · Appendix Disclosures3 hits
06
Includes a screenshot of a government database search result showing 'no results'.Moxian, Inc. (MOXC) · Wolfpack Research
Research note Short seller Beat · Appendix Disclosures3 hits
05
Includes a direct interview transcript as evidence of the business model's dependency.Goosehead Insurance, Inc. (GSHD) · Wolfpack Research
Research note Short seller Loop · Cost Of Inaction3 hits
09
Includes a direct quote from a former franchise recruiter illustrating the negative reputation.Goosehead Insurance, Inc. (GSHD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
10
The slide uses a 'villain critique' narrative style to highlight agency problems between management and shareholders.Goosehead Insurance, Inc. (GSHD) · Wolfpack Research
Research note Short seller 3 hits
11
The slide uses a dot plot to visualize the extreme valuation outlier status of GSHD compared to the insurance industry.Goosehead Insurance, Inc. (GSHD) · Wolfpack Research
Research note Short seller 3 hits
02
The diagram illustrates a circular flow of funds ($15M from IonQ to EPB, $7.5M in federal earmarks to EPB, $22M deal value from EPB to IonQ).IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The Monster3 hits
05
The slide uses a 'fraud-exposure' narrative to challenge the company's public narrative of commercial success.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The Monster3 hits
10
The slide uses a critical, investigative tone to challenge management's narrative regarding M&A strategy.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The Struggle3 hits
21
The slide presents evidence of budget cuts to specific programs to suggest insider trading or lack of transparency.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The New Order3 hits
22
The slide includes a table of budget line items and a bubble chart mapping military impact vs. maturity.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The New Order3 hits
04
This is a text-heavy research note page focusing on exposing a contradiction between corporate narrative and financial reality.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
05
Uses a comparison table to contrast R&D spend as a percentage of revenue, followed by a qualitative comparison of earnings call mentions.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
06
The slide uses a combination of a bar chart (deal value) and a line chart (deal count) to illustrate the market trend, followed by qualitative allegations about INOD's operations.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
08
The slide uses a comparative table to highlight the discrepancy between INOD's claimed AI capabilities and their actual operational efficiency.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
16
The slide uses a narrative structure to expose a recurring pattern of corporate deception.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Appendix Disclosure3 hits
06
The slide focuses on the RMB 1.61 billion discrepancy and critiques QTT's explanation of gross vs. net revenue reporting.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 3 hits
10
Includes a screenshot of a shareholder table from Qixin.com to prove Li Feng's involvement.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 3 hits
15
The slide uses visual comparison and red annotations to highlight the similarity between the motors.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
20
Contains excerpts from legal contracts and SEC filings to support allegations of sham revenue.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
24
Page 24 of 33. Combines a video-still illustration, narrative prose, a block pull-quote from EH's 20-F, and concluding analytical paragraph.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
30
The slide highlights a specific liability line item as evidence of a potential investor-to-creditor conversion and subsequent legal dispute.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
03
The slide uses a combination of narrative critique and a scientific diagram to frame the company's technology as potentially ineffective.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The Monster3 hits
10
The slide uses preclinical data to cast doubt on the clinical viability of the drug candidate.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The Monster3 hits
12
The slide uses a process diagram to illustrate the clinical trial design and highlights the lack of transparency in the dose-escalation phase.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The Monster3 hits
17
The slide lists bibliographic citations for three distinct studies, each with a brief summary of the research aim, methodology, and findings.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller 3 hits